. We show here that rabbit C-reactive protein has identical properties. Nevertheless, infection by Plasmodium yoelii sporozoites was not prevented in transgenic mice engineered to express rabbit C-reactive protein following induction of gluconeogenesis.
The role in malaria infection of acute-phase reactants, and in particular of C-reactive protein (CRP), is controversial. Some investigators have reported that rat and human CRPs bind to the surface membranes of Plasmodium yoelii (265 BY strain) and P. falciparum (NF54 strain) sporozoites and inhibit their further penetration and development in primary cultures of rat and human liver cells (5, 7) . In contrast, other investigators did not detect binding of human CRP to P. berghei (ANKA strain) sporozoites or its inhibitory effect on the penetration and development of P. berghei sporozoites in Hep-G2 cells (a human hepatoma cell line) (8) .
In an attempt to clarify these discrepancies, here we report the in vivo and in vitro effects of rabbit and human CRPs on the infectivity of P. berghei and P. yoelii (17X strain) sporozoites. We first showed by immunofluorescence with anti-CRP antibodies that rabbit and human CRPs reacted with methanol-fixed and live sporozoites of both P. yoelii and P. berghei, species that cause rodent malaria. This binding was observed only when CRPs were incubated with sporozoites in a calcium-rich medium (data not shown). This could explain why, in a previous study, no binding of human CRP to P. berghei sporozoites was observed (8) .
Next, we compared the ability of the CRPs to inhibit the development of P. berghei in Hep-G2 cells and the development of P. yoelii 17X and P. berghei in mouse primary cultures. Hep-G2 cells were cultured for 24 h before sporozoite inoculation in eight-chamber plastic Lab-Tek slides (Nunc, Inc., Naperville, Ill.) at 105 cells per well in minimum essential medium (MEM) containing 10% fetal calf serum and 1% penicillin-streptomycin (GIBCO, Gaithersburg, Md.) as previously described (2) . Mouse hepatocytes were isolated by collagenase perfusion of liver biopsies (3) and maintained for 24 h before sporozoite inoculation at a concentration of 6 x 104 per well in the Lab-Tek slides in the medium described above. The parasites were obtained by dissection of the salivary glands of Anopheles stephensi. Inhibition assays were performed by adding human or rabbit CRP (final concentration, 50 ,ug/ml) to (Table 1) .
To evaluate the effect of CRP in vivo, we used transgenic mice which express rabbit CRP from a phosphoenolpyruvate carboxykinase promoter. Expression of rabbit CRP responds to gluconeogenic signals in this system (9) . In contrast to CRP in humans, rabbits, or rats, CRP in mice is synthesized in trace amounts (6) . Groups of transgenic mice were kept for either 3 days on a high carbohydrate diet (4) to inhibit rabbit CRP expression or for 1 day on a isocaloric high protein diet (4) to induce rabbit CRP synthesis and then challenged with either 200 or 50 sporozoites of P. yoelii (17X strain). Although rabbit CRP was present at high concentrations in the transgenic mice on the protein diet, they were infected (Table 2) . Furthermore, no differences in the time of patency was observed between experimental and control Others have reported that the preincubation of P. berghei sporozoites with rat CRP inhibits their infectivity for rats (7) , but under these conditions the parasite viability might have been affected before injection into the animals. The present results are also relevant to the finding that rats treated with turpentine, a potent inducer of acute-phase proteins including CRPs, resist sporozoite infection (7) . On the basis of our findings, it seems likely that the turpentine-induced protection involves other acute-phase reactants beside CRP or other mechanisms such as the induction of nitric oxide metabolites (1). 
